cAMP信号通路与多发性骨髓瘤

国际肿瘤学杂志››2014,Vol. 41››Issue (5): 368-370.doi:10.3760/cma.j.issn.1673-422X.2014.05.015

王莹莹, 朱琦

00011 上海交通大学医学院附属第九人民医院血液内科

收稿日期:2013-12-05修回日期:2014-01-04出版日期:2014-05-08发布日期:2014-04-28
通讯作者:朱琦 E-mail:zhuqi70@hotmail.com
基金资助:

上海市自然科学基金（12ZR1416800）；上海市卫生局科研课题（2010101）

cAMP signaling pathway and multiple myeloma

Wang Yingying, Zhu Qi

Department of Hematology, Ninth People Hospital, Shanghai Jiaotong University Medical College, Shanghai 200011, China

Received:2013-12-05Revised:2014-01-04Online:2014-05-08Published:2014-04-28
Contact:ZHU Qi E-mail:zhuqi70@hotmail.com

摘要/Abstract

摘要：多发性骨髓瘤（MM）细胞克隆性增殖涉及细胞内多个信号通路。环腺苷酸（cAMP）信号通路作为一种重要的细胞内信息传递系统，与包括骨髓瘤细胞在内的多种恶性淋巴细胞增殖和凋亡的失调相关。靶向调变cAMP信号通路可以诱导包括骨髓瘤细胞在内的多种恶性淋巴细胞增殖阻滞和凋亡，其机制涉及线粒体介导细胞凋亡和cAMP调控多种细胞内递质。对cAMP介导骨髓瘤细胞凋亡深入研究分析，将为临床治疗MM提供可能途径和潜在靶点。

关键词:多发性骨髓瘤,环AMP,细胞凋亡

Abstract:The clonal proliferations of multiple myeloma cells consist of several signaling pathways. It has been shown that cyclic adenosine monophosphate (cAMP) signaling pathway, an important intracellular messenger delivery system, is related to abnormal proliferation and apoptosis of malignant lymphoid cells including myeloma cells. Manipulating the cAMP signaling pathway could induce cell cycle arrest and apoptosis of various malignant lymphoid cells including myeloma cells, which involve mitochondrialdependent apoptosis and cAMPmodulated changes of intracellular mediators. Indepth researches and analysis of cAMPinduced apoptosis in myeloma cells would provide potential targets and possible therapeutic means in the treatment of multiple myeloma.

Key words:Multiple myeloma,Cyclic AMP,Apoptosis

王莹莹, 朱琦. cAMP信号通路与多发性骨髓瘤[J]. 国际肿瘤学杂志, 2014, 41(5): 368-370.

Wang Yingying, Zhu Qi. cAMP signaling pathway and multiple myeloma[J]. Journal of International Oncology, 2014, 41(5): 368-370.

参考文献

［1］ Landgren O, Korde N. Multiple myeloma precursor disease: current clinical and epidemiological insights and future opportunities［J］. Oncology (Williston Park), 2011, 25(7): 589-590. ［2］ Insel PA, Zhang L, Murray F, et al. Cyclic AMP is both a proapoptotic and antiapoptotic second messenger［J］. Acta Physiol, 2012, 204(2):277-287. ［3］ Zhang L, Zambon AC, Vranizan K, et al. Gene expression signatures of cAMP/protein kinase A (PKA)promoted, mitochondrialdependent apoptosis. Comparative analysis of wildtype and cAMPdeathless S49 lymphoma cells［J］. J Biol Chem, 2008, 283(7):4304-4313. ［4］ Mantovani G, Bondioni S, Lania AG, et al. High expression of PKA regulatory subunit 1A protein is related to proliferation of human melanoma cells［J］. Oncogene, 2008， 27(13):1834-1843. ［5］ Bouizar Z, Ragazzon B, Viou L, et al. 8ClcAMP modifies the balance between PKAR1 and PKAR2 and modulates the cell cycle, growth and apoptosis in human adreoncortical H295R cells［J］. J Mol Endocrinol, 2010, 44(6):331-347. ［6］ FollinArbelet V, Hofgaard PO, Hauglin H, et al. Cyclic AMP induces apoptosis in multiple myeloma cells and inhibits tumor development in a mouse myeloma model［J］. BMC Cancer, 2011, 11: 301. ［7］ Rickles RJ, Pierce LT, Giordano TP 3rd, et al. Adenosine A2A receptor agonists and PDE inhibitors: a synergistic multitarget mechanism discovered through systematic combination screening in Bcell malignancies［J］. Blood, 2010, 116(4):593-602. ［8］郭玉琪, Zhenfeng Duan, 张展. IL6/STAT3信号传导通路及其在肿瘤靶向治疗中的作用［J］. 国际肿瘤学杂志, 2011, 38(6):427-429. ［9］ FollinArbelet V, Torgersen ML, Naderi EH, et al. Death of multiple myeloma cells induced by cAMPsignaling involves downregulation of Mcl1 via the JAK/STAT pathway［J］. Cancer Lett, 2013, 335(2):323-331. ［10］ Song J, Li Y, Shen B. Activation of PKA pathway inhibits reactivity of human myeloma cell lineU266 to IL6［J］. Zhonghua Zhong Liu Za Zhi, 2001, 23(4):278-280. ［11］ Baumann P, MandlWeber S, Emmerich B, et al. Inhibition of adenosine monophosphateactivated protein kinase induces apoptosis in multiple myeloma cells［J］. Anticancer Drugs, 2007, 18(4):405-410. ［12］ Leone V, di Palma A, Ricchi P, et al. PGE2 inhibits apoptosis in human adenocarcinoma Caco2 cell line through RasPI3K association and cAMPdependent kinase A activation［J］. Am J Physiol Gastrointest Liver Physiol, 2007, 293(4):G673-681. ［13］ McMurray JJ. Clinical practice. Systolic heart failure［J］. N Engl J Med, 2010, 362(3):228-238. ［14］ Misra UK, Pizzo SV. Coordinate regulation of forskolininduced cellular proliferation in macrophages by protein kinase A/cAMPresponse elementbinding protein (CREB) and Epac1Rap1 signaling: effects of silencing CREB gene expression on Akt activation［J］. J Biol Chem, 2005, 280(46):38276-38289.

[1]	任露, 谢晓丽, 张坤, 王丽娟.双氢青蒿素联合卡非佐米对多发性骨髓瘤细胞活性、增殖、凋亡的影响及机制研究[J]. 国际肿瘤学杂志, 2024, 51(3): 129-136.
[2]	张科平, 赵永生, 杨娟, 付茂勇.绿原酸通过抑制PI3K-Akt信号通路诱导肺癌A549细胞线粒体功能障碍[J]. 国际肿瘤学杂志, 2024, 51(1): 21-28.
[3]	向玉玲, 谭佳杰, 熊远果, 赵丽蓉, 黎晨, 张洪.脱水淫羊藿素对肝癌细胞增殖、迁移和凋亡的影响[J]. 国际肿瘤学杂志, 2023, 50(9): 513-519.
[4]	冯东旭, 吴炜, 高平发, 王军, 施丽娟, 陈大伟, 李文兵, 张美峰.miR-451通过调控Rho/ROCK1信号通路对乳腺癌细胞糖酵解及凋亡的影响[J]. 国际肿瘤学杂志, 2023, 50(8): 449-456.
[5]	吴佳丽, 张佳慧, 张萍, 肖昕悦, 李睿, 张红宇.Bcl-2 BH4选择性抑制剂BDA-366抑制NK/T细胞淋巴瘤细胞的机制研究[J]. 国际肿瘤学杂志, 2023, 50(7): 413-418.
[6]	杨娅, 王慧礼, 刘艳, 郭金凤, 王春霞, 吕敏, 山长平.GCSH基因在胃癌SNU-1细胞增殖和凋亡中的作用研究[J]. 国际肿瘤学杂志, 2023, 50(5): 257-262.
[7]	张雨潇, 张连生, 李莉娟.新型免疫检查点TIGIT在多发性骨髓瘤免疫治疗中的研究现状与应用前景[J]. 国际肿瘤学杂志, 2023, 50(2): 122-125.
[8]	朱易, 陈健.硫化氢在肿瘤发生发展中的作用机制及其供体抗肿瘤作用[J]. 国际肿瘤学杂志, 2023, 50(12): 729-733.
[9]	赵建昊, 段衍超.多发性骨髓瘤髓外病变发病机制的研究进展[J]. 国际肿瘤学杂志, 2023, 50(1): 55-59.
[10]	连海伟, 杨烁锐, 刘仁忠.金松双黄酮联合CX-4945通过Notch1通路调控胶质母细胞瘤细胞增殖与凋亡的机制研究[J]. 国际肿瘤学杂志, 2022, 49(6): 321-326.
[11]	杨娅, 宁晓飞, 李炳亮, 姚慧, 山长平, 吕敏.原花青素通过诱导活性氧产生介导抗SNU-1胃癌细胞株的作用机制研究[J]. 国际肿瘤学杂志, 2022, 49(5): 257-262.
[12]	高珊, 陆敏秋, 石磊, 褚彬, 房立娟, 项秋晴, 王宇彤, 丁月华, 鲍立.伊沙佐米联合方案治疗复发/难治多发性骨髓瘤的疗效和安全性分析[J]. 国际肿瘤学杂志, 2022, 49(5): 286-291.
[13]	蒋梦婷, 王家淳, 宗静.抑制NFAT5对肺腺癌细胞增殖、侵袭、迁移及凋亡能力的影响[J]. 国际肿瘤学杂志, 2021, 48(6): 321-327.
[14]	孙睿婕, 单宁宁.复发难治性多发性骨髓瘤的免疫靶向治疗及存在的问题[J]. 国际肿瘤学杂志, 2021, 48(6): 381-384.
[15]	王宪伟, 史美燕, 王凤芹, 齐福, 王朝喆, 周飞.TSA上调miR-4298靶向抑制PADI4表达在诱导U251细胞凋亡中的作用[J]. 国际肿瘤学杂志, 2021, 48(4): 193-199.